ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,200Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 300

$452K Total Retail Price of All Prescriptions

Rank: 40 out of 300

366 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 8,247 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 404 348 1 3
LEVOTHYROXINE SODIUM 291 287 2 12
AMLODIPINE BESYLATE 253 236 3 4
OMEPRAZOLE 244 225 4 2
LISINOPRIL 243 204 5 7
METOPROLOL SUCCINATE 226 209 6 15
METFORMIN HCL 208 178 7 24
FUROSEMIDE 195 173 8 5
FENOFIBRATE 191 155 9 73
MELOXICAM 186 184 10 14
WARFARIN SODIUM 173 164 11 23
HYDROCODONE-ACETAMINOPHEN 171 148 S3 12 1
ENALAPRIL MALEATE 167 167 13 56
NEXIUM 153 109 14 44
ATENOLOL 142 125 15 27
GLIMEPIRIDE 142 126 15 95
HYDROCHLOROTHIAZIDE 140 139 17 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 119 18 47
PRAVASTATIN SODIUM 119 111 19 17
LOSARTAN-HYDROCHLOROTHIAZIDE 118 107 20 76
PAROXETINE HCL 114 102 21 103
PANTOPRAZOLE SODIUM 107 83 22 45
TRICOR 107 97 22 230
POTASSIUM CHLORIDE 107 106 22 20
DIOVAN HCT 98 89 25 181
NAMENDA 97 97 26 61
TRIAMTERENE-HCTZ 97 91 26 112
ENALAPRIL-HYDROCHLOROTHIAZIDE 97 89 26 305
AZITHROMYCIN 92 80 29 71
AMOX TR-POTASSIUM CLAVULANATE 85 72 30 171
SERTRALINE HCL 74 61 31 40
METOPROLOL TARTRATE 73 69 32 26
TRILIPIX 73 71 32 327
DIOVAN 71 58 34 84
TAMSULOSIN HCL 69 63 35 9
GABAPENTIN 67 53 36 6
DONEPEZIL HCL 67 67 36 33
CELEBREX 66 63 38 114
ZOLPIDEM TARTRATE 64 51 39 16
ALENDRONATE SODIUM 63 63 40 79
TRAMADOL HCL 63 60 40 11
GLIPIZIDE 61 42 42 156
AMITRIPTYLINE HCL 60 49 R 43 43
CLONIDINE HCL 59 59 44 39
PLAVIX 58 48 45 32
CYCLOBENZAPRINE HCL 58 57 R 45 35
ATORVASTATIN CALCIUM 57 44 47 13
ALLOPURINOL 50 37 48 64
DILTIAZEM 24HR CD 50 50 48 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.